Detalhe da pesquisa
1.
Use of anti-viral therapies in hospitalised COVID-19 patients in the United Arab Emirates: a cost-effectiveness and health-care resource use analysis.
BMC Health Serv Res
; 23(1): 383, 2023 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37081467
2.
Long-term health and economic benefits of switching to tenofovir alafenamide versus continuing on entecavir in chronic hepatitis B patients with low-level viremia in Saudi Arabia.
Saudi J Gastroenterol
; 30(1): 23-29, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37417192
3.
Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey.
Pragmat Obs Res
; 14: 13-27, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36873793
4.
Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions.
JHEP Rep
; 4(1): 100411, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34977520
5.
Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study.
Clin Drug Investig
; 42(8): 669-678, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35838880
6.
Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment.
Pharmacoeconomics
; 39(11): 1327-1341, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34396494
7.
Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait.
Hepatol Int
; 15(4): 912-921, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33822317
8.
Hepatitis B care pathway in Jordan: current situation, gaps and recommended actions.
J Virus Erad
; 6(1): 1-6, 2020 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32175084